Search results
View Michael Teufel’s profile on LinkedIn, a professional community of 1 billion members.
- 500+
- 1.6K
- Boehringer Ingelheim
- Ridgefield CT
Our commitment to innovation has resulted in pioneering treatments for lung cancer and we are now advancing a unique clinical development pipeline of new therapeutic agents, both...
Michael Teufel's 30 research works with 988 citations and 1,670 reads, including: Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal...
Abstract. Background & aims: In a phase 3 trial (RESORCE), regorafenib increased overall survival compared with placebo in patients with hepatocellular carcinoma (HCC) previously treated with sorafenib.
- Michael Teufel, Henrik Seidel, Karl Köchert, Gerold Meinhardt, Richard S. Finn, Josep M. Llovet, Jor...
- 2019
View Michael Teufel’s profile on LinkedIn, a professional community of 1 billion members. Experience: Evisort · Education: TC Beirne School of Law, The University of Queensland, Australia.
- 500+
- Evisort
- 7.7K
- Portland, Oregon, United States
Michael V. Teufel, CPA is a tax preparer in Jackson, New Jersey. Find address location, qualification, AFSP status, contact number, reviews etc. for Michael V. Teufel, CPA.
Michael Teufel, et al. Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma Table S1 Proteins (112/266) for which baseline plasma concentration was significantly associated with OS (adjusted p≤0.05)
